Long-term effects for acute phase myocardial infarct VEGF₁₆₅ gene transfer cardiac extracellular matrix remodeling

References

• Almeida PC, Nantes IL, Chagas JR, Rizzi CCA, Faljoni-Alario A, Carmona E, Julianoi L, Nader HB, Tersariol ILS. Cathepsin B activity regulation. Heparin-like glycosaminoglycans protect human cathepsin B from alkaline pH-induced inactivation. J Biol Chem 2001; 276: 944–951
   PubMed Web of Science ®Google Scholar
• Bernfield M, Gotte M, Park PW, Reizes O, Fitzgerald ML, Lincecum J, Zako M. Functions of cell surface heparan sulfate proteoglycans. Annu Rev Biochem 1999; 68: 729–777
   PubMed Web of Science ®Google Scholar
• Chen WYJ, Abatangelo G. Functions of hyaluronan in wound repair. Wound Rep Reg 1999; 7: 79–89
   PubMed Web of Science ®Google Scholar
• Dietrich CP, Dietrich SMC. Electrophoretic behaviour of acidic mucopolysaccharides in diamine buffers. Anal Biochem 1976; 70: 645–647
   PubMed Web of Science ®Google Scholar
• Fam NP, Verma S, Kutryk M, Stewart DJ. Clinician guide to angiogenesis. Circulation 2003; 108: 2613–2618
   PubMed Web of Science ®Google Scholar
• Ferrara N. Role of vascular endothelial growth factor in the regulation of angiogenesis. Kidney Int 1999; 56: 794–814
   PubMed Web of Science ®Google Scholar
• Finsen AV, Woldbaek PR, Li J, Wu J, Lyberg T, Tonnessen T, Christensen G. Increased syndecan expression following myocardial infarction indicates a role in cardiac remodeling. Physiol Genomics 2004; 16: 301–308
   PubMed Web of Science ®Google Scholar
• Gallagher JT. Heparan sulfate: Growth control with a restricted sequence menu. J Clin Invest 2001; 108: 357–361
   PubMed Web of Science ®Google Scholar
• Henke CA, Roongta U, Mickelson DJ, Knutson JR, McCarthy JB. CD44-related Chondroitin sulfate proteoglycan, a cell surface receptor implicated with tumor cell invasion, mediates endothelial cell migration on fibrinogen and invasion into a fibrin matrix. J Clin Invest 1996; 97: 2541–2552
   PubMed Web of Science ®Google Scholar
• Hinton RB, Lincoln L, Deutsch GH, Osinska H, Manning PB, Benson DW, Yutzey KE. Extracellular matrix remodeling and organization in developing and diseased aortic valves. Circ Res 2006; 98: 1431–1438
   PubMed Web of Science ®Google Scholar
• Horton MR, Burdick MD, Strieter RM, Bao C, Noble PW. Regulation of hyaluronan-induced chemokine gene expression by IL-10 and IFN-g in mouse macrophages. J Immunol 1998; 160: 3023–3030
   PubMedGoogle Scholar
• Itano N, Sawai T, Yoshida M, Lenas P, Yamada Y, Imagawa M, Shinomura T, Hamaguchi M, Yoshida Y, Ohnuki Y, Miyauchi S, Spicer AP, McDonald JA, Kimata K. Three isoforms of mammalian hyaluronan synthases have distinct enzymatic properties. J Biol Chem 1999; 274: 25085–25092
   PubMed Web of Science ®Google Scholar
• Kizaki K, Okada M, Ito R, Yoshioka K, Hashizume K, Mutoh K, Hara Y. Induction of heparanase gene expression in ventricular myocardium of rats with isoproterenol-induced cardiac hypertrophy. Biol Pharm Bull 2005; 28: 2331–2334
   PubMedGoogle Scholar
• Kreuger J, Spillmann D, Li J, Lindal U. Interactions between heparan sulfate and proteins: The concept of specificity. JCB 2006; 174: 323–327
   PubMed Web of Science ®Google Scholar
• Laurent TC, Fraser JR. Hyaluronan. Faseb J 1992; 6: 2397–2404
   PubMed Web of Science ®Google Scholar
• Li J, Brown LF, Laham RJ, Volk R, Simons M. Macrophage-dependent regulation of syndecan gene expression. Circ Res 1997; 81: 785–796
   PubMed Web of Science ®Google Scholar
• Lindsey ML, Mann DL, Entman ML, Spinale FG. Extracellular matrix remodeling following myocardial injury. Ann Med 2003; 35: 316–326
   PubMed Web of Science ®Google Scholar
• Martins JR, Passerotti CC, Maciel RM, Sampaio LO, Dietrich CP, Nader HB. Practical determination of hyaluronan by a new noncompetitive fluorescence-based assay on serum of normal and cirrhotic patients. Anal Biochem 2003; 319: 65–72
   PubMed Web of Science ®Google Scholar
• Melo LG, Pachori AS, Kong D, Gnecchi M, Wang K, Pratt RE, Dzau VJ. Molecular and cell-based therapies for protection, rescue, and repair of ischemic myocardium reasons for cautious optimism. Circulation 2004; 109: 2386–2393
   PubMed Web of Science ®Google Scholar
• Milinkovic M, Antin JH, Hergrueter CA, Underhill CB, Sackstein R. CD44-hyaluronic acid interactions mediate shear-resistant binding of lymphocytes to dermal endothelium in acute cutaneous GVHD. Blood 2004; 103: 740–742
   PubMed Web of Science ®Google Scholar
• Mizutani K, Kawashima S, Ueyama T, Sakoda T, Takeuchi S, Kobayashi S, Yokoyama M, Hayashi Y, Itoh H. Heparin and heaparan sulfate inhibit extracellular signal-regulated kinase activation and myocardial cell hypertrophy induced by endothelin-1. Kobe J Med Sci 2001; 47: 47–58
   PubMedGoogle Scholar
• Moisés VA, Ferreira RL, Nozawa E, Kanashiro RM, Campos Fo O, Andrade JL, Carvalho ACC, Tucci PJF. Structural and functional characteristics of rat hearts with and without myocardial infarct. Initial experience with Doppler echocardiography. Arq Bras Cardiol 2000; 75: 125–136
   PubMedGoogle Scholar
• Nader HB, Ferreira TMPC, Paiva JF, Medeiros MGL, Jerônimo SMB, Paiva VMPP, Dietrich CP. Isolation and structural studies of heparan sulfates and chondroitin sulfates from three species of molluscs. J Biol Chem 1984; 259: 1431–1435
   PubMed Web of Science ®Google Scholar
• Nader HB, Porcionatto MA, Tersariol IL, Pinhal MA, Oliveira FW, Moraes CT, Dietrich CP. Flavobacterium heparinum. Analyses of the heparin and heparan sulfate degradation products by 13C NMR spectroscopy. J Biol Chem 1990; 265: 16807–16813
   PubMed Web of Science ®Google Scholar
• Noulas AV, Theochari AD, Feretis E, Papageorgakopoulou N, Karamanos NK, Theocharis DA. Pig vitreous gel: Macromolecular composition with particular reference to hyaluronan-binding proteoglycans. Biochimie 2002; 84: 295–302
   PubMed Web of Science ®Google Scholar
• Raio L, Cromi A, Ghezzi F, Passi A, Karousou E, Viola M, Vigetti D, De Luca G, Bolis P. Hyaluronan content of Wharton's jelly in healthy and Down syndrome fetuses. Matrix Biol 2005; 24: 166–174
   PubMed Web of Science ®Google Scholar
• Rodgers LS, Lalani S, Hardy KM, Xiang X, Broka D, Antin PB, Camenisch TD. Depolymerized hyaluronan induces vascular endothelial growth factor, a negative regulator of developmental epithelial-to-mesenchymal transformation. Circ Res 2006; 99: 583
   PubMed Web of Science ®Google Scholar
• Rosenberg RD, Shworak NW, Liu J, Schwartz JJ, Zhang L. Heparan sulfate proteoglycans of the cardiovascular system. Specific structures emerge but how is synthesis regulated?. J Clin Invest 1997; 99: 2062–2070
   PubMed Web of Science ®Google Scholar
• Skrzydlewska E, Sulkowska M, Koda M, Sulkowski S. Proteolytic–antiproteolytic balance and its regulation in carcinogenesis. World J Gastroenterol 2005; 11: 1251–1266
   PubMed Web of Science ®Google Scholar
• Spadaro J, Fishbein MC, Hare C, Pfeffer MA, Maroko PR. Characterization of myocardial infarcts in the rat. Arch Pathol Lab Med 1980; 104: 179–183
   PubMedGoogle Scholar
• Suarez ER, Nohara AS, Mataveli FD, de Matos LL, Nader HB, Pinhal MAS. Glycosaminoglycan synthesis and shedding induced by growth factors are cell and compound specific. Growth Factors 2007; 25: 50–59
   PubMed Web of Science ®Google Scholar
• Sugahara KN, Hirata T, Murai T, Miyasaka M. Hyaluronan oligosaccharides and tumor progression. TIGG 2004; 16: 187–197
   Google Scholar
• Taylor KR, Gallo RL. Glycosaminoglycans and their proteoglycans: Host-associated molecular patterns for initiation and modulation of inflammation. FASEB J 2006; 20: 9–22
   PubMed Web of Science ®Google Scholar
• Tempel C, Gilead A, Neeman M. Hyaluronic acid as an anti-angiogenic shield in the preovulatory rat follicle. Biol Reprod 2000; 63: 134–140
   PubMed Web of Science ®Google Scholar
• Tessler S, Rockwell P, Hicklin D, Cohenln T, Levin B, Larry Lemischkall WIR, Neufeld G. Heparin modulates the interaction of VEGF165 with soluble and cell associated flk-1 receptors. J Biol Chem 1994; 269: 12456–12461
   PubMed Web of Science ®Google Scholar
• Tkachenko E, Elfeinbien A, Tirziu D, Simons M. Syndecan-4 clustering induces cell migration in a PDZ-dependent manner. Circ Res 2006; 98: 1398–1404
   PubMedGoogle Scholar
• Vlodavsky I, Friedmann Y. Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis. J Clin Invest 2001; 108: 341–347
   PubMed Web of Science ®Google Scholar
• Waltenberger J. Modulation of growth factor action. Implications for the treatment of cardiovascular diseases. Circulation 1997; 96: 4083–4094
   PubMed Web of Science ®Google Scholar
• Yamauchi H, Desgranges P, Lecerf L, Papy-Garcia D, Tournaire M, Moczar M, Loisance D, Barritault D. New agents for the treatment of infarcted myocardium. The FASEB J 2000; 14: 2133–2134
   PubMedGoogle Scholar
• Zetser A, Levy-Adam F, Kaplan V, Gingis-Velitski S, Bashenko Y, Schubert S, Flugelman MY, Vlodavsky I, Ilan N. Heparanase is a endo-β-d-glucoronidase specific for heparan sulfate cleavage. Processing and activation of latent heparanase occurs in lysosomes. J Cell Sci 2004; 117: 2249–2258
   PubMedGoogle Scholar
• Zhang Y, Pasparakis M, Kollias G, Simons M. Myocyte-dependent regulation of endothelial cell syndecan-4 expression. J Biol Chem 1999; 274: 14786–14790
   PubMed Web of Science ®Google Scholar
• Zhang Y, Li J, Partovian C, Sellke FW, Simons M. Syndecan-4 modulates basic fibroblast growth factor 2 signaling in vivo. Am J Physiol Heart Circ Physiol 2003; 284: 2078–2082
   PubMedGoogle Scholar